3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
5
Genitourinary
2
CNS
2
Gastrointestinal
1
Conditions
Brain Neoplasms
1902
Glioblastoma
1795
Glioma
1127
Central Nervous System Neoplasms
599
Astrocytoma
593
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
363
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
226
Recurrence
199
Sarcoma
183
Neoplasm Metastasis
183
Melanoma
181
Meningioma
177
Ependymoma
175
Lung Neoplasms
157
Lymphoma
133
Osteosarcoma
126
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
100
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
Sirolimus
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Otorhinolaryngologic Diseases
×
CNS
×
Clear all
NCT07267910
2026-05-27
VESTI
Aalto University
Phase NA
Not yet recruiting
30 enrolled
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled